AIDS mortality in South Africa has seen an observed decrease at the population level from 2006-09 — the first time since the epidemic began, according to Jeffrey Klausner, MD, of the Centers for Disease Control and Prevention (CDC) in Pretoria. He presented on the impact of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) […]
Dr. Sten H. Vermund – a member of the Center’s Scientific Advisory Board – released a new report in Current HIV/AIDS Reports this week on the significance, challenges and opportunities in combination HIV prevention strategies. He suggests that these “prevention packages” be scaled up and their effectiveness evaluated.
A Lancet article this week examines the Stop TB Partnership. The piece outlines challenges to tuberculosis control and proposes solutions. It argues that treatment should be integrated into efforts to reduce poverty and treatment of other diseases that often co-exist with tuberculosis, and specific goals should be set to “inspire new partners to push for tuberculosis elimination.”
This week, the World Health Organization released its first report on neglected tropical diseases. Erin Hohlfelder at the ONE blog has a good post on the significance of this publication, saying it is the end of “report neglect” on NTDs.
The Accordia Global Health Foundation is currently accepting applications for the second annual Merle A. Sande Health Leadership Award. The award will be given to an emerging African leader who has contributed to the field of infectious diseases in Africa with the same passion, intellectual drive, and spirit of the founder of the Accordia Foundation […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]